

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 7.04458478 |
| 2 | muscle filament sliding (GO:0030049) | 7.04458478 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.53072702 |
| 4 | skeletal muscle contraction (GO:0003009) | 6.08187945 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.75092148 |
| 6 | actin-mediated cell contraction (GO:0070252) | 5.67674025 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 5.52572833 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.45204360 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.38526712 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.14205030 |
| 11 | vocalization behavior (GO:0071625) | 5.09746001 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.07999164 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.85569357 |
| 14 | glutamate secretion (GO:0014047) | 4.84394563 |
| 15 | striated muscle contraction (GO:0006941) | 4.81926970 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.78436039 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.72963334 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.69258651 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.64221524 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54506042 |
| 21 | skeletal muscle fiber development (GO:0048741) | 4.51104996 |
| 22 | protein localization to synapse (GO:0035418) | 4.50585691 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.45752113 |
| 24 | creatine metabolic process (GO:0006600) | 4.44914171 |
| 25 | proline transport (GO:0015824) | 4.42937971 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.36193965 |
| 27 | regulation of relaxation of muscle (GO:1901077) | 4.34116780 |
| 28 | actin filament-based movement (GO:0030048) | 4.31309251 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30199469 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.28838148 |
| 31 | regulation of cell communication by electrical coupling (GO:0010649) | 4.27783047 |
| 32 | exploration behavior (GO:0035640) | 4.20759439 |
| 33 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.18854644 |
| 34 | myofibril assembly (GO:0030239) | 4.17764185 |
| 35 | response to inactivity (GO:0014854) | 4.16406476 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 4.15772017 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 4.14670562 |
| 38 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.12164971 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 4.08663934 |
| 40 | neurotransmitter secretion (GO:0007269) | 4.06382988 |
| 41 | myotube cell development (GO:0014904) | 3.96091253 |
| 42 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.95067504 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.92125871 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.89725129 |
| 45 | cardiac muscle contraction (GO:0060048) | 3.85510844 |
| 46 | response to muscle activity (GO:0014850) | 3.80837275 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.80296282 |
| 48 | neuron cell-cell adhesion (GO:0007158) | 3.77278113 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75002303 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69347205 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 3.67217182 |
| 52 | muscle contraction (GO:0006936) | 3.63744168 |
| 53 | sarcomere organization (GO:0045214) | 3.63478501 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.61188159 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 3.59478031 |
| 56 | long-term memory (GO:0007616) | 3.58444872 |
| 57 | auditory behavior (GO:0031223) | 3.58409977 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.54150636 |
| 59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54109667 |
| 60 | regulation of synapse maturation (GO:0090128) | 3.53427832 |
| 61 | activation of protein kinase A activity (GO:0034199) | 3.52718002 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.47418711 |
| 63 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.46586291 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.45800053 |
| 65 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44883345 |
| 66 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44883345 |
| 67 | positive regulation of membrane potential (GO:0045838) | 3.43476602 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 3.42213365 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.38443435 |
| 70 | prepulse inhibition (GO:0060134) | 3.38175907 |
| 71 | regulation of postsynaptic membrane potential (GO:0060078) | 3.34832918 |
| 72 | cardiac myofibril assembly (GO:0055003) | 3.32800003 |
| 73 | behavioral fear response (GO:0001662) | 3.30798265 |
| 74 | behavioral defense response (GO:0002209) | 3.30798265 |
| 75 | cellular potassium ion homeostasis (GO:0030007) | 3.30395790 |
| 76 | membrane depolarization during action potential (GO:0086010) | 3.29096232 |
| 77 | muscle fiber development (GO:0048747) | 3.27560672 |
| 78 | neurotransmitter transport (GO:0006836) | 3.27297365 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 3.26928705 |
| 80 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.25226985 |
| 81 | muscle system process (GO:0003012) | 3.24899974 |
| 82 | response to auditory stimulus (GO:0010996) | 3.23358915 |
| 83 | cell migration in hindbrain (GO:0021535) | 3.22151756 |
| 84 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.21625087 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 3.20756940 |
| 86 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.20701602 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20022067 |
| 88 | regulation of membrane repolarization (GO:0060306) | 3.16704757 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.13268821 |
| 90 | regulation of dendritic spine development (GO:0060998) | 3.11713909 |
| 91 | neuron recognition (GO:0008038) | 3.11092714 |
| 92 | regulation of actin filament-based movement (GO:1903115) | 3.10656052 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.10234755 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.08187096 |
| 95 | sodium ion export (GO:0071436) | 3.07357799 |
| 96 | neuronal ion channel clustering (GO:0045161) | 3.07057128 |
| 97 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.07018873 |
| 98 | regulation of neurotransmitter levels (GO:0001505) | 3.04038191 |
| 99 | mitochondrion transport along microtubule (GO:0047497) | 3.03227340 |
| 100 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.03227340 |
| 101 | membrane depolarization (GO:0051899) | 3.02566270 |
| 102 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02404541 |
| 103 | regulation of vesicle fusion (GO:0031338) | 3.02344639 |
| 104 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.01984706 |
| 105 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.01984706 |
| 106 | fear response (GO:0042596) | 3.01761436 |
| 107 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.00920120 |
| 108 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00849931 |
| 109 | striatum development (GO:0021756) | 2.99703298 |
| 110 | regulation of neurotransmitter secretion (GO:0046928) | 2.99521238 |
| 111 | dendritic spine organization (GO:0097061) | 2.99376953 |
| 112 | postsynaptic membrane organization (GO:0001941) | 2.98580054 |
| 113 | potassium ion import (GO:0010107) | 2.97955244 |
| 114 | cardiac muscle hypertrophy (GO:0003300) | 2.97801182 |
| 115 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.95669610 |
| 116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.94830806 |
| 117 | synaptic vesicle endocytosis (GO:0048488) | 2.94632227 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.94227404 |
| 119 | dendrite morphogenesis (GO:0048813) | 2.94063954 |
| 120 | axonal fasciculation (GO:0007413) | 2.93816756 |
| 121 | neuromuscular process (GO:0050905) | 2.91021264 |
| 122 | skeletal muscle tissue development (GO:0007519) | 2.89576449 |
| 123 | striated muscle adaptation (GO:0014888) | 2.89195468 |
| 124 | positive regulation of myotube differentiation (GO:0010831) | 2.87794761 |
| 125 | long-term synaptic potentiation (GO:0060291) | 2.87575998 |
| 126 | actomyosin structure organization (GO:0031032) | 2.86724622 |
| 127 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86057229 |
| 128 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84643147 |
| 129 | learning (GO:0007612) | 2.83229859 |
| 130 | striated muscle hypertrophy (GO:0014897) | 2.82598315 |
| 131 | skeletal muscle adaptation (GO:0043501) | 2.81607599 |
| 132 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.81588726 |
| 133 | neuromuscular process controlling posture (GO:0050884) | 2.80685749 |
| 134 | regulation of neurotransmitter transport (GO:0051588) | 2.80422983 |
| 135 | cell communication by electrical coupling (GO:0010644) | 2.80356004 |
| 136 | plasma membrane repair (GO:0001778) | 2.80210757 |
| 137 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.79772391 |
| 138 | dopamine receptor signaling pathway (GO:0007212) | 2.78650246 |
| 139 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78419354 |
| 140 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.78401666 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77867905 |
| 142 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.77391726 |
| 143 | intraspecies interaction between organisms (GO:0051703) | 2.77144337 |
| 144 | social behavior (GO:0035176) | 2.77144337 |
| 145 | vesicle transport along microtubule (GO:0047496) | 2.77099790 |
| 146 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.75918857 |
| 147 | chemosensory behavior (GO:0007635) | 2.75129894 |
| 148 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.75103194 |
| 149 | membrane hyperpolarization (GO:0060081) | 2.75049225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.71398863 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.20400742 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93865628 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.83716063 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79742126 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75941536 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75941536 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71952420 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.67768357 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57213317 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.43649350 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42754233 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40617034 |
| 14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40458911 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38584608 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37905789 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.36060172 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33163199 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31008128 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27046119 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25459556 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24648015 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22776467 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20758994 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11328881 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.98648058 |
| 27 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.95621079 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94445838 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85525251 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79082426 |
| 31 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.78593728 |
| 32 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.74664077 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70858965 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66574142 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.61104132 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59920223 |
| 37 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56867563 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51150637 |
| 39 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.50708023 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.49912105 |
| 41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.49481755 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48424591 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47788101 |
| 44 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47137837 |
| 45 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.42467423 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35981947 |
| 47 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34076719 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32660676 |
| 49 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.32208427 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29930431 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29450818 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26601382 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21733045 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21548493 |
| 55 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.20807189 |
| 56 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19259591 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18079978 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.17640578 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16941086 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16644966 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16175672 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15031893 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14505616 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13913850 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10741559 |
| 66 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10120825 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08479646 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07886233 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07286753 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07221221 |
| 71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07134429 |
| 72 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07047029 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06982871 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06076933 |
| 75 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06018462 |
| 76 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06018462 |
| 77 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06018462 |
| 78 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05943272 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05188632 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05178843 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03822423 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02578719 |
| 83 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00741121 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99574511 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99574511 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98872208 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97499710 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96016159 |
| 89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95269128 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94725641 |
| 91 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94162020 |
| 92 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93551172 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92748892 |
| 94 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92515168 |
| 95 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91799629 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91437273 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90390375 |
| 98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90243134 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89572390 |
| 100 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.89167511 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88841883 |
| 102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88661050 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88554238 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88523221 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88286165 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86996476 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86909666 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86601494 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 0.86334607 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85683561 |
| 111 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84863337 |
| 112 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84379805 |
| 113 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.84266930 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82063007 |
| 115 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81878325 |
| 116 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.81425294 |
| 117 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81108914 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80017467 |
| 119 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.79033308 |
| 120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.78533587 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78248540 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78222616 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78202819 |
| 124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77856416 |
| 125 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77751732 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77032317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.51254624 |
| 2 | MP0004270_analgesia | 4.10058682 |
| 3 | MP0003880_abnormal_central_pattern | 4.05047579 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.87308795 |
| 5 | MP0002822_catalepsy | 3.48465183 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.15994977 |
| 7 | MP0009745_abnormal_behavioral_response | 3.03651437 |
| 8 | MP0002064_seizures | 2.77676212 |
| 9 | MP0004858_abnormal_nervous_system | 2.70788617 |
| 10 | MP0009046_muscle_twitch | 2.66964649 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.59058564 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.48936337 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.44300250 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.44015378 |
| 15 | MP0001486_abnormal_startle_reflex | 2.41840415 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.39008839 |
| 17 | MP0002272_abnormal_nervous_system | 2.19605148 |
| 18 | MP0000751_myopathy | 2.18318793 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.90541331 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.89732329 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.89394580 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.87268382 |
| 23 | MP0000749_muscle_degeneration | 1.80182674 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.77818494 |
| 25 | MP0001970_abnormal_pain_threshold | 1.75503436 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.74519882 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.71694802 |
| 28 | MP0002184_abnormal_innervation | 1.69655094 |
| 29 | MP0003122_maternal_imprinting | 1.66802587 |
| 30 | MP0008569_lethality_at_weaning | 1.65842174 |
| 31 | MP0000955_abnormal_spinal_cord | 1.61507716 |
| 32 | MP0002736_abnormal_nociception_after | 1.61467116 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.61068965 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.57359930 |
| 35 | MP0000778_abnormal_nervous_system | 1.56729500 |
| 36 | MP0005499_abnormal_olfactory_system | 1.56657105 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.56657105 |
| 38 | MP0000733_abnormal_muscle_development | 1.56008072 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.55519584 |
| 40 | MP0005451_abnormal_body_composition | 1.55518860 |
| 41 | MP0003787_abnormal_imprinting | 1.50103644 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.49755477 |
| 43 | MP0003646_muscle_fatigue | 1.46151236 |
| 44 | MP0004924_abnormal_behavior | 1.42081181 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.42081181 |
| 46 | MP0003329_amyloid_beta_deposits | 1.37328219 |
| 47 | MP0005330_cardiomyopathy | 1.33951482 |
| 48 | MP0000747_muscle_weakness | 1.32752069 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.31954698 |
| 50 | MP0002972_abnormal_cardiac_muscle | 1.30327140 |
| 51 | * MP0002066_abnormal_motor_capabilities/c | 1.28865720 |
| 52 | MP0001529_abnormal_vocalization | 1.26474575 |
| 53 | MP0003879_abnormal_hair_cell | 1.23424826 |
| 54 | MP0004510_myositis | 1.19562389 |
| 55 | MP0004885_abnormal_endolymph | 1.19033855 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.16089331 |
| 57 | * MP0000759_abnormal_skeletal_muscle | 1.15987391 |
| 58 | MP0002269_muscular_atrophy | 1.15781744 |
| 59 | MP0003283_abnormal_digestive_organ | 1.13666857 |
| 60 | MP0001984_abnormal_olfaction | 1.13248219 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.12830120 |
| 62 | MP0004142_abnormal_muscle_tone | 1.12410032 |
| 63 | MP0003137_abnormal_impulse_conducting | 1.10621340 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.10413002 |
| 65 | MP0003633_abnormal_nervous_system | 1.09371720 |
| 66 | MP0006292_abnormal_olfactory_placode | 1.09341276 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.08774031 |
| 68 | MP0004233_abnormal_muscle_weight | 1.08231985 |
| 69 | * MP0002106_abnormal_muscle_physiology | 1.04373990 |
| 70 | MP0002152_abnormal_brain_morphology | 1.01306232 |
| 71 | MP0008872_abnormal_physiological_respon | 1.00036897 |
| 72 | MP0001905_abnormal_dopamine_level | 0.99039467 |
| 73 | MP0003123_paternal_imprinting | 0.98707099 |
| 74 | MP0002653_abnormal_ependyma_morphology | 0.98442610 |
| 75 | MP0004085_abnormal_heartbeat | 0.97783515 |
| 76 | MP0008874_decreased_physiological_sensi | 0.93913252 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.92641186 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.91695497 |
| 79 | * MP0005369_muscle_phenotype | 0.91386988 |
| 80 | * MP0005620_abnormal_muscle_contractility | 0.90762069 |
| 81 | * MP0004087_abnormal_muscle_fiber | 0.89562804 |
| 82 | MP0004036_abnormal_muscle_relaxation | 0.89344578 |
| 83 | MP0010630_abnormal_cardiac_muscle | 0.89118876 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.87360726 |
| 85 | MP0003075_altered_response_to | 0.87287277 |
| 86 | MP0006138_congestive_heart_failure | 0.85340320 |
| 87 | MP0003631_nervous_system_phenotype | 0.84312416 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.84123768 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.82444374 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.81808856 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.79151861 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.78464673 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.77996859 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.76592875 |
| 95 | MP0004043_abnormal_pH_regulation | 0.76528834 |
| 96 | MP0002254_reproductive_system_inflammat | 0.76513985 |
| 97 | MP0004130_abnormal_muscle_cell | 0.76376820 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.76018583 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.75202022 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.73633821 |
| 101 | MP0002229_neurodegeneration | 0.72892177 |
| 102 | MP0000920_abnormal_myelination | 0.72419282 |
| 103 | MP0003938_abnormal_ear_development | 0.71879021 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.71309800 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.71309800 |
| 106 | MP0001502_abnormal_circadian_rhythm | 0.71236343 |
| 107 | MP0003121_genomic_imprinting | 0.70703959 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.70619698 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.68040351 |
| 110 | MP0003690_abnormal_glial_cell | 0.67341007 |
| 111 | MP0003861_abnormal_nervous_system | 0.66105434 |
| 112 | MP0004484_altered_response_of | 0.64884192 |
| 113 | MP0003634_abnormal_glial_cell | 0.64813862 |
| 114 | MP0003045_fibrosis | 0.63558371 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.63366274 |
| 116 | MP0005535_abnormal_body_temperature | 0.63271158 |
| 117 | MP0001943_abnormal_respiration | 0.62816262 |
| 118 | MP0005266_abnormal_metabolism | 0.62259587 |
| 119 | MP0002971_abnormal_brown_adipose | 0.61893282 |
| 120 | MP0003890_abnormal_embryonic-extraembry | 0.61509443 |
| 121 | MP0008770_decreased_survivor_rate | 0.58146557 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.56489933 |
| 123 | MP0001963_abnormal_hearing_physiology | 0.55157954 |
| 124 | MP0004134_abnormal_chest_morphology | 0.54395729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.94099489 |
| 2 | Focal motor seizures (HP:0011153) | 5.86743695 |
| 3 | Focal seizures (HP:0007359) | 4.73801663 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.32960967 |
| 5 | Visual hallucinations (HP:0002367) | 4.28982225 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 4.28311395 |
| 7 | Calcaneovalgus deformity (HP:0001848) | 4.02769105 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.89852366 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.84795759 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.75917209 |
| 11 | Febrile seizures (HP:0002373) | 3.66423701 |
| 12 | Difficulty running (HP:0009046) | 3.59104374 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 3.58724536 |
| 14 | Deformed tarsal bones (HP:0008119) | 3.52603276 |
| 15 | Myoglobinuria (HP:0002913) | 3.49360245 |
| 16 | Atonic seizures (HP:0010819) | 3.43734800 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.40823217 |
| 18 | Subaortic stenosis (HP:0001682) | 3.40394662 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.40394662 |
| 20 | Neck muscle weakness (HP:0000467) | 3.37045277 |
| 21 | Rhabdomyolysis (HP:0003201) | 3.32882934 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.22373652 |
| 23 | Rimmed vacuoles (HP:0003805) | 3.21680964 |
| 24 | Nemaline bodies (HP:0003798) | 3.21305743 |
| 25 | Absent phalangeal crease (HP:0006109) | 3.18876400 |
| 26 | Dialeptic seizures (HP:0011146) | 3.18784467 |
| 27 | Absence seizures (HP:0002121) | 3.17945365 |
| 28 | Ankle clonus (HP:0011448) | 3.17467830 |
| 29 | Amblyopia (HP:0000646) | 3.16530472 |
| 30 | Exercise-induced muscle cramps (HP:0003710) | 3.12712653 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 3.06637144 |
| 32 | Fetal akinesia sequence (HP:0001989) | 3.02654721 |
| 33 | Frequent falls (HP:0002359) | 3.01843253 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.01245611 |
| 35 | Hyperventilation (HP:0002883) | 2.86332638 |
| 36 | Type 1 muscle fiber predominance (HP:0003803) | 2.85007392 |
| 37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.84783883 |
| 38 | Action tremor (HP:0002345) | 2.83241173 |
| 39 | Broad-based gait (HP:0002136) | 2.80553120 |
| 40 | Distal arthrogryposis (HP:0005684) | 2.79434405 |
| 41 | Progressive cerebellar ataxia (HP:0002073) | 2.78521405 |
| 42 | Resting tremor (HP:0002322) | 2.77877760 |
| 43 | Poor eye contact (HP:0000817) | 2.77654434 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.75985829 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71309464 |
| 46 | Depression (HP:0000716) | 2.70927217 |
| 47 | Bilateral microphthalmos (HP:0007633) | 2.67030570 |
| 48 | Myopathic facies (HP:0002058) | 2.66077241 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.63481172 |
| 50 | Amyotrophic lateral sclerosis (HP:0007354) | 2.62797826 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.58240705 |
| 52 | Myotonia (HP:0002486) | 2.58049616 |
| 53 | Abnormal finger flexion creases (HP:0006143) | 2.57839111 |
| 54 | Impaired social interactions (HP:0000735) | 2.53626848 |
| 55 | Abnormal social behavior (HP:0012433) | 2.53626848 |
| 56 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53125320 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.50740909 |
| 58 | Hemiparesis (HP:0001269) | 2.46414388 |
| 59 | Urinary urgency (HP:0000012) | 2.46241344 |
| 60 | Scapular winging (HP:0003691) | 2.46137083 |
| 61 | Gowers sign (HP:0003391) | 2.46039355 |
| 62 | Hip contracture (HP:0003273) | 2.45266981 |
| 63 | Round ear (HP:0100830) | 2.44336502 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.43756405 |
| 65 | Dysdiadochokinesis (HP:0002075) | 2.42620368 |
| 66 | Lower limb amyotrophy (HP:0007210) | 2.41863578 |
| 67 | Hepatoblastoma (HP:0002884) | 2.41096093 |
| 68 | Fatigable weakness (HP:0003473) | 2.38925864 |
| 69 | Abnormality of the neuromuscular junction (HP:0003398) | 2.38925864 |
| 70 | Abnormality of the calcaneus (HP:0008364) | 2.38560122 |
| 71 | Postural instability (HP:0002172) | 2.38518350 |
| 72 | Calf muscle hypertrophy (HP:0008981) | 2.37701180 |
| 73 | Weak cry (HP:0001612) | 2.36868936 |
| 74 | Neoplasm of the heart (HP:0100544) | 2.35493435 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 2.34973546 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.34458410 |
| 77 | Areflexia of lower limbs (HP:0002522) | 2.34394896 |
| 78 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.34299405 |
| 79 | EMG: myopathic abnormalities (HP:0003458) | 2.34276810 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.33439471 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.29868592 |
| 82 | Foot dorsiflexor weakness (HP:0009027) | 2.29249555 |
| 83 | Bulbar palsy (HP:0001283) | 2.27907152 |
| 84 | Annular pancreas (HP:0001734) | 2.25222064 |
| 85 | Akinesia (HP:0002304) | 2.25171148 |
| 86 | Anxiety (HP:0000739) | 2.22704027 |
| 87 | Mutism (HP:0002300) | 2.20919337 |
| 88 | Dysmetria (HP:0001310) | 2.19702902 |
| 89 | Limb-girdle muscle atrophy (HP:0003797) | 2.16988662 |
| 90 | Generalized hypotonia (HP:0001290) | 2.15815539 |
| 91 | Drooling (HP:0002307) | 2.15651014 |
| 92 | Excessive salivation (HP:0003781) | 2.15651014 |
| 93 | Abnormality of the corticospinal tract (HP:0002492) | 2.15477955 |
| 94 | Rapidly progressive (HP:0003678) | 2.13502875 |
| 95 | Lower limb muscle weakness (HP:0007340) | 2.13195822 |
| 96 | Slender build (HP:0001533) | 2.12705268 |
| 97 | Spastic gait (HP:0002064) | 2.12049254 |
| 98 | Gaze-evoked nystagmus (HP:0000640) | 2.08375595 |
| 99 | Shoulder girdle muscle weakness (HP:0003547) | 2.07480771 |
| 100 | Papilledema (HP:0001085) | 2.07166086 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06885780 |
| 102 | Impaired vibratory sensation (HP:0002495) | 2.05842922 |
| 103 | Torticollis (HP:0000473) | 2.03417247 |
| 104 | Testicular atrophy (HP:0000029) | 2.02695741 |
| 105 | Bradykinesia (HP:0002067) | 2.02524481 |
| 106 | Difficulty climbing stairs (HP:0003551) | 2.02306092 |
| 107 | Nonprogressive disorder (HP:0003680) | 2.01646267 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 2.01296080 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 2.01039912 |
| 110 | Genetic anticipation (HP:0003743) | 1.99871016 |
| 111 | Abnormality of the calf musculature (HP:0001430) | 1.99396356 |
| 112 | Heart block (HP:0012722) | 1.98709090 |
| 113 | Ankyloglossia (HP:0010296) | 1.98544868 |
| 114 | Stereotypic behavior (HP:0000733) | 1.98488537 |
| 115 | Diplopia (HP:0000651) | 1.98291125 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.98291125 |
| 117 | Waddling gait (HP:0002515) | 1.97870652 |
| 118 | Popliteal pterygium (HP:0009756) | 1.96700329 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.96624990 |
| 120 | Abnormal eating behavior (HP:0100738) | 1.95154126 |
| 121 | Hyperkalemia (HP:0002153) | 1.94969247 |
| 122 | Spinal rigidity (HP:0003306) | 1.94673267 |
| 123 | Truncal ataxia (HP:0002078) | 1.94432191 |
| 124 | Status epilepticus (HP:0002133) | 1.93508529 |
| 125 | Metatarsus adductus (HP:0001840) | 1.92911549 |
| 126 | Horizontal nystagmus (HP:0000666) | 1.91567812 |
| 127 | Ulnar deviation of the wrist (HP:0003049) | 1.91007637 |
| 128 | Dysmetric saccades (HP:0000641) | 1.88364168 |
| 129 | Abnormal atrioventricular conduction (HP:0005150) | 1.87161336 |
| 130 | Impaired smooth pursuit (HP:0007772) | 1.85753502 |
| 131 | Abnormal EKG (HP:0003115) | 1.85500854 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.84229293 |
| 133 | Focal dystonia (HP:0004373) | 1.84168846 |
| 134 | Inability to walk (HP:0002540) | 1.83727690 |
| 135 | Increased connective tissue (HP:0009025) | 1.83312114 |
| 136 | Pointed chin (HP:0000307) | 1.83236247 |
| 137 | Sudden death (HP:0001699) | 1.83093545 |
| 138 | Bundle branch block (HP:0011710) | 1.82715488 |
| 139 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.81516341 |
| 140 | Upper limb amyotrophy (HP:0009129) | 1.81120555 |
| 141 | Distal upper limb amyotrophy (HP:0007149) | 1.81120555 |
| 142 | Proximal amyotrophy (HP:0007126) | 1.80801062 |
| 143 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.78137489 |
| 144 | Muscle stiffness (HP:0003552) | 1.77833091 |
| 145 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77091754 |
| 146 | Limited hip movement (HP:0008800) | 1.75819314 |
| 147 | Limb dystonia (HP:0002451) | 1.72629961 |
| 148 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.69141279 |
| 149 | Muscle fiber atrophy (HP:0100295) | 1.65424168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.67420038 |
| 2 | MAP3K9 | 3.94964772 |
| 3 | NTRK3 | 3.84456289 |
| 4 | GRK5 | 2.85006067 |
| 5 | MARK1 | 2.82232101 |
| 6 | PRKD3 | 2.40675388 |
| 7 | DAPK2 | 2.34726411 |
| 8 | MAP3K4 | 2.28301420 |
| 9 | PAK6 | 2.25077593 |
| 10 | MINK1 | 2.21640834 |
| 11 | TYRO3 | 2.21314480 |
| 12 | MAP2K4 | 2.13155884 |
| 13 | NTRK1 | 2.10543707 |
| 14 | KSR2 | 2.05227052 |
| 15 | NTRK2 | 1.98559580 |
| 16 | PHKG1 | 1.89499810 |
| 17 | PHKG2 | 1.89499810 |
| 18 | CDK12 | 1.58565502 |
| 19 | CAMKK1 | 1.55737815 |
| 20 | MAP2K7 | 1.54255275 |
| 21 | RIPK4 | 1.51250514 |
| 22 | KSR1 | 1.47426601 |
| 23 | PIK3CG | 1.45781341 |
| 24 | CDK5 | 1.42542909 |
| 25 | OBSCN | 1.41823386 |
| 26 | TAOK1 | 1.39044607 |
| 27 | STK38 | 1.38586207 |
| 28 | SIK2 | 1.36501627 |
| 29 | DAPK1 | 1.31804376 |
| 30 | MARK2 | 1.29762599 |
| 31 | LATS2 | 1.24512838 |
| 32 | GRK6 | 1.18730679 |
| 33 | MAP3K7 | 1.09584694 |
| 34 | PRPF4B | 1.08709992 |
| 35 | NME1 | 1.07621742 |
| 36 | PRKCG | 1.06941079 |
| 37 | LIMK1 | 1.05955124 |
| 38 | CAMK2G | 1.03467161 |
| 39 | MOS | 1.02753704 |
| 40 | PINK1 | 1.02079049 |
| 41 | NEK1 | 0.96844398 |
| 42 | ARAF | 0.95503081 |
| 43 | CDK15 | 0.94064479 |
| 44 | UHMK1 | 0.93327323 |
| 45 | CDK18 | 0.93189136 |
| 46 | MAPK13 | 0.92191974 |
| 47 | CDK19 | 0.91151368 |
| 48 | ALK | 0.90524728 |
| 49 | MAP3K12 | 0.90335839 |
| 50 | CAMK4 | 0.90184856 |
| 51 | FES | 0.89292989 |
| 52 | WNK1 | 0.88385625 |
| 53 | CDK14 | 0.86080130 |
| 54 | PKN1 | 0.85390405 |
| 55 | CDK11A | 0.83591368 |
| 56 | MAP3K13 | 0.83576735 |
| 57 | CAMK1 | 0.82886697 |
| 58 | MAPK12 | 0.82312238 |
| 59 | MAPK7 | 0.81115351 |
| 60 | PLK2 | 0.80851858 |
| 61 | STK11 | 0.80460598 |
| 62 | ADRBK2 | 0.80278363 |
| 63 | TNIK | 0.78941976 |
| 64 | MAP3K2 | 0.76873696 |
| 65 | SGK2 | 0.73985034 |
| 66 | DYRK1B | 0.72537643 |
| 67 | PRKCH | 0.71062637 |
| 68 | CCNB1 | 0.69703880 |
| 69 | CASK | 0.69131178 |
| 70 | MAP2K3 | 0.68961745 |
| 71 | MAP3K11 | 0.66942565 |
| 72 | CAMK2A | 0.65683021 |
| 73 | PDK1 | 0.65579316 |
| 74 | MAP2K6 | 0.64420114 |
| 75 | RET | 0.63540268 |
| 76 | RAF1 | 0.63317630 |
| 77 | PAK3 | 0.62879713 |
| 78 | ICK | 0.62633667 |
| 79 | DMPK | 0.61772659 |
| 80 | MATK | 0.61686185 |
| 81 | PTK2B | 0.61363620 |
| 82 | PNCK | 0.60048520 |
| 83 | PDK4 | 0.59108005 |
| 84 | PDK3 | 0.59108005 |
| 85 | EEF2K | 0.59048307 |
| 86 | DYRK1A | 0.58702386 |
| 87 | PRKAA1 | 0.58473250 |
| 88 | SGK1 | 0.56028383 |
| 89 | RIPK1 | 0.55421352 |
| 90 | RPS6KA3 | 0.55136168 |
| 91 | GRK7 | 0.54903640 |
| 92 | MAPK10 | 0.52891947 |
| 93 | MAPK4 | 0.52347135 |
| 94 | TRIB3 | 0.50986150 |
| 95 | PDPK1 | 0.50357520 |
| 96 | CAMK2D | 0.48513803 |
| 97 | PRKG1 | 0.47353083 |
| 98 | TTN | 0.46830805 |
| 99 | CAMKK2 | 0.45619291 |
| 100 | RPS6KA2 | 0.45434498 |
| 101 | SIK1 | 0.45272438 |
| 102 | SGK223 | 0.45099809 |
| 103 | SGK494 | 0.45099809 |
| 104 | ROCK1 | 0.44935167 |
| 105 | TNK2 | 0.42958643 |
| 106 | DDR2 | 0.42729113 |
| 107 | AKT2 | 0.41805732 |
| 108 | LMTK2 | 0.41241043 |
| 109 | SGK3 | 0.40786089 |
| 110 | CAMK2B | 0.40694251 |
| 111 | MAP3K1 | 0.40678699 |
| 112 | MUSK | 0.39405414 |
| 113 | ADRBK1 | 0.39224277 |
| 114 | PRKD2 | 0.39189240 |
| 115 | MAPKAPK3 | 0.38750148 |
| 116 | PRKCZ | 0.36864504 |
| 117 | FYN | 0.35474293 |
| 118 | DAPK3 | 0.34295735 |
| 119 | BRAF | 0.34230296 |
| 120 | MAP2K1 | 0.33854578 |
| 121 | PRKACA | 0.33363843 |
| 122 | TESK1 | 0.31556217 |
| 123 | MAPK8 | 0.29099272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.99010869 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.86018074 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79771605 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57770522 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50286237 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49248802 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43147778 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36531604 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.26838659 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22916771 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.21279698 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03950249 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.02268353 |
| 14 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88016855 |
| 15 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.87188965 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84861127 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83673776 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81088936 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.76615478 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76383260 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73851500 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.69439413 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.63140306 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.58394681 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55246672 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54647247 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.53284872 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52204882 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.47623941 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.35268668 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.28250221 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26781331 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26540632 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26372606 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.23314052 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23112689 |
| 37 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17831285 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10340279 |
| 39 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09856670 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09854085 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09584543 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08850744 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08397771 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.07651557 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05846265 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05676684 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05647133 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.04561816 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99402198 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97568793 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95402797 |
| 52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92238694 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90898720 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90345455 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87376767 |
| 56 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86141772 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83972649 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83417796 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82105049 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81239064 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80650789 |
| 62 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80599507 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80315067 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78086187 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76168191 |
| 66 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75829771 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75427228 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74966913 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74135439 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73222512 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67402083 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67310101 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65833881 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65601213 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64359540 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64275823 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62260614 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62124120 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.61233738 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60068232 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59444003 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57523543 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57133947 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57055740 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.56176669 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54503184 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53225655 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53198146 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53171096 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52528698 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51298894 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50998445 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50676300 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50613165 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.50515855 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49982851 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45522590 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.44743753 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44721471 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.44492243 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43368859 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.43266401 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43099888 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41978683 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.40504278 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40478358 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38553608 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38188023 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36878087 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.36215659 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36033391 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35587337 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35441283 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35424730 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35211214 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32985276 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29506460 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29007977 |

